BE903183A - Nouveaux derives du benzonorbornene, leurs procedes de preparation et composition medicamenteuse et cosmetique les contenant - Google Patents

Nouveaux derives du benzonorbornene, leurs procedes de preparation et composition medicamenteuse et cosmetique les contenant

Info

Publication number
BE903183A
BE903183A BE0/215545A BE215545A BE903183A BE 903183 A BE903183 A BE 903183A BE 0/215545 A BE0/215545 A BE 0/215545A BE 215545 A BE215545 A BE 215545A BE 903183 A BE903183 A BE 903183A
Authority
BE
Belgium
Prior art keywords
medicinal
novel
composition containing
cosmetic composition
preparation methods
Prior art date
Application number
BE0/215545A
Other languages
English (en)
Inventor
G Lang
J Maignan
S Restle
B Shroot
Original Assignee
Oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from LU85531A external-priority patent/LU85531A1/fr
Priority claimed from LU85700A external-priority patent/LU85700A1/fr
Application filed by Oreal filed Critical Oreal
Publication of BE903183A publication Critical patent/BE903183A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/782—Ketones containing a keto group bound to a six-membered aromatic ring polycyclic
    • C07C49/792—Ketones containing a keto group bound to a six-membered aromatic ring polycyclic containing rings other than six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00—Compounds having —CHO groups
    • C07C47/52—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings
    • C07C47/546—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings polycyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/80—Ketones containing a keto group bound to a six-membered aromatic ring containing halogen
    • C07C49/813—Ketones containing a keto group bound to a six-membered aromatic ring containing halogen polycyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/84—Ketones containing a keto group bound to a six-membered aromatic ring containing ether groups, groups, groups, or groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Saccharide Compounds (AREA)
  • Detergent Compositions (AREA)

Abstract

Un composé de formule (I) ses isomères et ses sels, dans lesquels - R1, R3 et R4 représentent, indépendamment l'un de l'autre, un atome d'hydrogène, un radical alkyle C1-C8, un radical alkoxy C1-C8, un atome d'halogène, un radical acyloxy C1-C8 ou un radical hydroxyle; - R' représente un atome d'hydrogène ou un radical alkyle C1-C6; - R'' représente un groupement insaturé, qui est, soit une chaine polyénique, soit un noyau benzénique. L'invention concerne également deux procédés de préparation des composés de formule (I) ainsi que les compositions médicamenteuse et cosmétique les contenant. Les composé de formule (I) sont utilisé pour le traitement d'affections dermatologiques et en ophtalmologie.
BE0/215545A 1984-09-05 1985-09-05 Nouveaux derives du benzonorbornene, leurs procedes de preparation et composition medicamenteuse et cosmetique les contenant BE903183A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
LU85531A LU85531A1 (fr) 1984-09-05 1984-09-05 Nouveaux derives du benzonorbornene,leur procede de preparation et compositions medicamenteuse et cosmetique les contenant
LU85700A LU85700A1 (fr) 1984-12-20 1984-12-20 Nouveaux derives du benzonorbornene,leurs procedes de preparation et compositions medicamenteuse et cosmetique les contenant

Publications (1)

Publication Number Publication Date
BE903183A true BE903183A (fr) 1986-03-05

Family

ID=26640307

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/215545A BE903183A (fr) 1984-09-05 1985-09-05 Nouveaux derives du benzonorbornene, leurs procedes de preparation et composition medicamenteuse et cosmetique les contenant

Country Status (10)

Country Link
US (4) US4783549A (fr)
JP (1) JP2618225B2 (fr)
BE (1) BE903183A (fr)
CA (2) CA1272448A (fr)
CH (1) CH667868A5 (fr)
DE (1) DE3531722C2 (fr)
FR (1) FR2569689B1 (fr)
GB (1) GB2164644B (fr)
IT (1) IT1203635B (fr)
NL (1) NL192721C (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2599031B1 (fr) * 1986-05-23 1988-07-22 Oreal Nouveaux composes naphtyl aromatiques, leur procede de preparation et leur utilisation en medecine humaine et veterinaire et en cosmetique
FR2617476B1 (fr) * 1987-07-03 1989-11-17 Oreal Nouveaux derives polycycliques aromatiques, leur procede de preparation et leur utilisation en medecine humaine et veterinaire et en cosmetique
US5194664A (en) * 1989-02-10 1993-03-16 Basf Aktiengesellschaft Aromatic keto compounds, the preparation thereof, and drugs and cosmetics containing these
US7655699B1 (en) 1992-04-22 2010-02-02 Eisai Inc. Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors
US5324840A (en) 1992-06-11 1994-06-28 Allergan, Inc. Method of treatment with compounds having retinoid-like activity and reduced skin toxicity and lacking teratogenic effects
US5455265A (en) * 1993-02-11 1995-10-03 Allergan, Inc. Method of treatment with compounds having selective agonist-like activity on RXR retinoid receptors
US6172115B1 (en) 1993-02-11 2001-01-09 Allergan Sales, Inc. Method for preventing onset of restenosis after angioplasty employing an RXR-specific retinoid
CA2129773C (fr) * 1993-09-02 2007-05-01 Michael Klaus Derives d'acides carboxyliques aromatiques
US7115728B1 (en) 1995-01-30 2006-10-03 Ligand Pharmaceutical Incorporated Human peroxisome proliferator activated receptor γ
WO1997012853A1 (fr) * 1995-10-06 1997-04-10 Ligand Pharmaceuticals Incorporated Modulateurs rxr selectifs pour les dimeres et leurs methodes d'utilisation
WO1999005161A1 (fr) * 1997-07-25 1999-02-04 Ligand Pharmaceuticals Incorporated SEQUENCES REGULATRICES DU GENE HUMAIN PPARη (RECEPTEUR GAMMA ACTIVE DE LA PROLIFERATION DES PEROXYSOMES) ET LEURS UTILISATIONS
EP1093362A1 (fr) * 1998-06-12 2001-04-25 Ligand Pharmaceuticals Incorporated Traitement du cancer du sein resistant aux anti-oestrogenes avec des modulateurs de rxr
MXPA02002032A (es) 1999-08-27 2003-05-19 Ligand Pharm Inc Compuestos moduladores del receptor de androgeno y metodos.
US6566372B1 (en) * 1999-08-27 2003-05-20 Ligand Pharmaceuticals Incorporated Bicyclic androgen and progesterone receptor modulator compounds and methods
EP1212322A2 (fr) 1999-08-27 2002-06-12 Ligand Pharmaceuticals Incorporated Composes de 6-trifluoromethyl-9-pyrido[3,2-g]quinoline 8-substitues utilises comme modulateurs de recepteurs androgenes
EP1216221A2 (fr) * 1999-09-14 2002-06-26 Ligand Pharmaceuticals Incorporated Modulateurs rxr a profil pharmacologique ameliore
US9050310B2 (en) * 2004-06-25 2015-06-09 Minas Theodore Coroneo Treatment of ocular lesions
US20060204474A1 (en) * 2005-02-25 2006-09-14 Coroneo Minas T Treatment of epithelial layer lesions
WO2012076842A1 (fr) * 2010-12-09 2012-06-14 University Of Durham Rétinoïdes synthétiques pour le contrôle de la différenciation des cellules
BR112014015062A2 (pt) * 2011-12-21 2017-06-13 Firmenich & Cie odorizadores amadeirados
KR20150119468A (ko) 2013-02-28 2015-10-23 더미라, 인코포레이티드 글리코피롤레이트 염
US8558008B2 (en) 2013-02-28 2013-10-15 Dermira, Inc. Crystalline glycopyrrolate tosylate
US9006462B2 (en) 2013-02-28 2015-04-14 Dermira, Inc. Glycopyrrolate salts
US11045441B2 (en) 2015-10-13 2021-06-29 Wisconsin Alumni Research Foundation Use of retinoic acid and analogs thereof to treat central neural apneas

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU77254A1 (fr) * 1977-05-04 1979-01-18
US4326055A (en) * 1977-12-22 1982-04-20 Hoffmann-La Roche Inc. Stilbene derivatives
FI67386C (fi) * 1979-06-21 1985-03-11 Hoffmann La Roche Foerfarande foer framstaellning av nya terapeutiskt anvaendbara sockerderivat
DE3202100A1 (de) * 1982-01-23 1983-08-04 Basf Ag, 6700 Ludwigshafen Substituierte benzoesaeure-4-hydroxyanilide, ihre herstellung und diese enthaltende pharmazeutische zubereitungen
US4439614A (en) * 1982-09-22 1984-03-27 Sri International 5,6-Methano-5,6-dihydroretinoids
EP0155940A1 (fr) * 1983-08-08 1985-10-02 Sri International Analogues des acides benzonorbornenyle, benzopyranyle et benzothiopyranyle retinoiques

Also Published As

Publication number Publication date
IT8567757A0 (it) 1985-09-05
GB2164644B (en) 1988-04-27
FR2569689B1 (fr) 1990-11-16
CH667868A5 (fr) 1988-11-15
GB8522082D0 (en) 1985-10-09
US5053547A (en) 1991-10-01
NL8502439A (nl) 1986-04-01
DE3531722C2 (de) 1995-07-06
NL192721B (nl) 1997-09-01
CA1272448A (fr) 1990-08-07
CA1267153A (fr) 1990-03-27
NL192721C (nl) 1998-01-06
JPS61126038A (ja) 1986-06-13
JP2618225B2 (ja) 1997-06-11
FR2569689A1 (fr) 1986-03-07
GB2164644A (en) 1986-03-26
DE3531722A1 (de) 1986-03-06
IT1203635B (it) 1989-02-15
US5198567A (en) 1993-03-30
US4783549A (en) 1988-11-08
US4931589A (en) 1990-06-05

Similar Documents

Publication Publication Date Title
BE903183A (fr) Nouveaux derives du benzonorbornene, leurs procedes de preparation et composition medicamenteuse et cosmetique les contenant
CA2065117A1 (fr) Derives s-triaziniques portant des substituants benzalmalonates, leur procede de preparation, compositions cosmetiques filtrantes les contenant et leur utilisation pour proteger la peau et les cheveux du rayonnement ultraviolet
FR2416234A1 (fr) Derives de metronidazole et compositions pharmaceutiques en contenant
BE903334A (fr) Nouveaux derives naphtaleniques a action retinoique, leurs procedes de preparation et compositions medicamenteuse et cosmetique les contenant
BE901224A (fr) Nouveaux derives d'indole utiles comme medicaments et intermediaires et procedes pour leur preparation.
FR2708605A1 (fr) Dérivés du N-sulfonylindol-2-one, leur préparation, les compositions pharmaceutiques en contenant.
FR2416012A1 (fr) Derives de l'imidazole et medicament contenant ces substances
EP0379416A3 (fr) Dérivés d'azabicycloheptène et leurs sels, leur procédé de préparation, leur application comme médicaments et les compositions les renfermant
FR2708606A1 (fr) Dérivés du N-phénylalkylindol-2-one, leur préparation, les compositions pharmaceutiques en contenant.
FR2430412A1 (fr) Derives substitues de propanolamine utiles comme medicaments et procede de leur preparation
BE902897A (fr) Derives 3-aminopropoxyaryliques, leur preparation leur application comme medicaments et compositions pharmaceutiques les contenant
FR2708608A1 (fr) Dérivés de N-sulfonylbenzimidazolone, leur préparation, les compositions pharmaceutiques en contenant.
BE900856A (fr) Compositions pour combattre la toxemie.
FR2430410A1 (fr) Phenethanolamines et compositions pharmaceutiques en contenant
BE900855A (fr) Compositions pour le traitement prophylactique de l'osteite et de l'osteomyelite.
BE900345A (fr) Composition pharmaceutique ophtalmiques a base d'un derive d'acide phenylacetique.
ATE60579T1 (de) Pyrrolidinamid-derivate mit antipropylendopeptidase-wirkung, zusammenstellungen, die sie enthalten, verfahren zu ihrer herstellung und heilmittel, die sie enthalten.
BE904757A (fr) Esters gras bi-ou tri-eniques d'erythromycine a, leur procede de preparation et compositons pharmaceutiques et cosmetiques les contenant.
FR2358382A1 (fr) Nouveaux nonapeptides, leurs procedes de preparation et compositions pharmaceutiques les contenant
FR2367750A1 (fr) Acid
FR2636946A1 (fr) ((diarylmethoxy)alcoyl)-1 pyrrolidines et piperidines, procedes de preparation et medicaments les contenant
FR2393577A1 (fr) Medicament a base d'acide b-(p-halogenophenyl)-g-aminobutyrique destine au traitement de la nevrose d'angoisse
FR2637286A1 (fr) Nouveaux derives benzoxazolinoniques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
BE1002220A3 (fr) Nouveaux derives tertiobutyles du benzylidene camphre, leur procede de preparation, leur utilisation en tant qu'agents anti-oxydants et compositions pharmaceutiques et cosmetiques les contenant.
FR2405067A1 (fr) Compositions pharmaceutiques contenant des derives monofonctionnels du psoralene pour le traitement des affections cutanees

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: L *OREAL

Effective date: 20050905

RE20 Patent expired

Owner name: L *OREAL

Effective date: 20050905